Physician profile
Janel Lloyd
NPI 1326008525
$1,535.71
in general payments reported to CMS, 2019-2025
13 companies · $331 in 2025
The $331 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $74.23 · 2021: $227 · 2022: $253 · 2023: $270 · 2024: $162 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $764.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $763.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $289.83 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Pfizer INC. | $268.49 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $238.62 | 2019-2025 | Elaprase, Vpriv |
| Corium, LLC | $191.73 | 2022-2025 | Azstarys |
| Glaxosmithkline, LLC. | $189.36 | 2019-2025 | Bexsero, Pediarix |
| Sanofi Pasteur INC. | $170.17 | 2019-2025 | |
| Sobi, INC | $43.24 | 2022 | |
| Kaleo, INC. | $43.14 | 2021 | |
| Seqirus USA INC | $33.95 | 2022-2024 | Flucelvax |
| Ironshore Pharmaceuticals INC. | $20.58 | 2019 | |
| Agile Therapeutics, INC. | $17.22 | 2024 | Twirla |
| Lnhc, INC | $15.42 | 2025 | Zelsuvmi |
| Shire North American Group INC | $13.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janel Lloyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.